Cervical Cancer Global Clinical Trials Review, H1, 2017

  • ID: 4331306
  • Clinical Trials
  • Region: Global
  • 504 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Advaxis Inc
  • AstraZeneca Plc
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline Plc
  • Merck & Co Inc
  • MORE
Cervical Cancer Global Clinical Trials Review, H1, 2017

Summary

The author's clinical trial report, “Cervical Cancer Global Clinical Trials Review, H1, 2017" provides an overview of Cervical Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Cervical Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). The author's Clinical Trial Reports are generated using the proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Scope
  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months
Reasons to buy
  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Advaxis Inc
  • AstraZeneca Plc
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline Plc
  • Merck & Co Inc
  • MORE
Report Guidance
Clinical Trials Report Coverage
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Cervical Cancer to Oncology Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Cervical Cancer to Oncology Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Cervical Cancer Therapeutics Clinical Trials
Prominent Drugs
Latest Clinical Trials News on Cervical Cancer
Jun 02, 2017: Opdivo (nivolumab) Data in Patients with Advanced Cervical, Vaginal and Vulvar Cancers from Phase 1/2 CheckMate -358 Presented at ASCO
May 18, 2017: Advaxis to Host Investor & Analyst Day on June 12
Apr 18, 2017: Lion Biotechnologies Highlights Publication of New Translational Data in Science for TIL Therapy for Treatment of Cervical Cancer
Mar 27, 2017: Advaxis Provides Phase 1 Data of Higher Dose Axalimogene Filolisbac
Mar 23, 2017: Vaccibody Announces Vaccination Of First Patient In Its Phase IIA Study With VB10.16 Immunotherapy For Patients With HPV16 Induced High Grade Lesions Of The Cervix
Mar 15, 2017: Advaxis Presents Oral Late-breaking Data on Phase 2 GOG-0265 Study of Axalimogene Filolisbac at SGO’s Annual Meeting on Women’s Cancer
Clinical Trial Profile Snapshots
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About
Contact
Disclaimer
Source

List of Tables
Cervical Cancer Therapeutics, Global, Clinical Trials by Region, 2017*
Cervical Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017*
Cervical Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017*
Cervical Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017*
Cervical Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2017*
Cervical Cancer Therapeutics Clinical Trials, North America, Top Countries, 2017*
Cervical Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017*
Cervical Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017*
Proportion of Cervical Cancer to Oncology Clinical Trials, G7 Countries (%), 2017*
Cervical Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2017*
Cervical Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017*
Proportion of Cervical Cancer to Oncology Clinical Trials, E7 Countries (%), 2017*
Cervical Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2017*
Cervical Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017*
Cervical Cancer Therapeutics, Global, Clinical Trials by Phase, 2017*
Cervical Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2017*
Cervical Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2017*
Cervical Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2017*
Cervical Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016
Cervical Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017*
Cervical Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2017*
Cervical Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017*
Cervical Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017*

List of Figures
Cervical Cancer Therapeutics, Global, Clinical Trials by Region (%), 2017*
Cervical Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017*
Cervical Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017*
Cervical Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017*
Cervical Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017*
Cervical Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2017*
Cervical Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017*
Cervical Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017*
Proportion of Cervical Cancer to Oncology Clinical Trials, G7 Countries (%), 2017*
Cervical Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2017*
Cervical Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017*
Proportion of Cervical Cancer to Oncology Clinical Trials, E7 Countries (%), 2017*
Cervical Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2017*
Cervical Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017*
Cervical Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2017*
Cervical Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2017*
Cervical Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2017*
Cervical Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2017*
Cervical Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016
Cervical Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017*
Cervical Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2017*
Cervical Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017*
Cervical Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017*
Methodology
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • GlaxoSmithKline Plc
  • Merck & Co Inc
  • AstraZeneca Plc
  • F. Hoffmann-La Roche Ltd
  • Pfizer Inc
  • Bristol-Myers Squibb Company
  • Sanofi
  • Advaxis Inc
  • Novartis AG
  • Eli Lilly and Company
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll